8. Shareholders’ Equity:

Dividends

On January 23, 2013, the Company’s Board of Directors approved the payment of a $0.04 per share quarterly cash dividend to shareholders of record at the close of business on February 6, 2013, which was paid on March 1, 2013.

Repurchase of Common Stock

In the first three months of 2013 the Company repurchased 4,756 shares of its common stock for an aggregate price of $269,600 or $56.69 per share. Under the Board of Directors’ authorization, as of March 30, 2013, the Company has the ability to repurchase an additional 356,396 shares of its common stock. Repurchases may be made from time to time at prevailing prices, subject to certain restrictions on volume, pricing and timing.

Stock Option Plans and Stock-Based Compensation

The Company had authorized up to 750,000 shares of common stock be reserved for granting either nonqualified or incentive stock options to officers and key employees under the Company’s 2001 Stock Option Plan (the “2001 Plan”). The 2001 Plan expired on February 20, 2011. The Company has authorized up to 250,000 shares of common stock to be reserved for granting either nonqualified or incentive stock options to officers and key employees under the Company’s 2010 Stock Option Plan (the “2010 Plan”).

The Company also sponsors a Stock Option Plan for Nonemployee Directors (the “Nonemployee Directors Plan”) and has reserved a total of 300,000 shares for issuance to directors of the Company who are not employees.

Stock option activity under the 2001 Plan, 2010 Plan and Nonemployee Directors Plan (collectively, the “Option Plans”) as of March 30, 2013 was as follows:

	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (years)	Intrinsic Value
Outstanding at December 29, 2012	613,727		$	31.46	7.06	$	16,010,000
Exercised	(7,944	)	15.18
Outstanding at March 30, 2013	605,783		$	31.68	6.81	$	18,968,900
Exercisable at March 30, 2013	343,519		$	21.94	5.55	$	14,100,800

No options were granted during the three months ended March 30, 2013 or the three months ended March 31, 2012. All unexercised options at March 30, 2013 have an exercise price equal to the fair market value on the date of the grant.

Compensation expense of $261,700 and $205,400 relating to the vested portion of the fair value of stock options granted was expensed to “Selling, General and Administrative Expenses” in the first three months of 2013 and 2012, respectively. As of March 30, 2013, the Company had $2.4 million of total unrecognized compensation expense related to stock options that is expected to be recognized over the remaining weighted average vesting period of approximately 2.5 years.